02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 44.48
−1.29%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.13x
- Debt / assets
- 0.04x
- Debt / EBITDA
- 0.29x
- Net debt / EBITDA
- -0.65x
Liquidity & coverage
- Current ratio
- 3.04x
- Quick ratio
- 2.82x
- Cash ratio
- 1.59x
- Interest coverage
- 74.60x
- EBITDA / interest
- 92.48x
- Working capital
- HKD 19.7B
Cash & dividend
- FCF / debt
- 1.62x
- Cash flow / debt
- 3.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026